INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Vitamin D therapy improved lung function, walking distance, symptoms, and exacerbations in patients with COPD.

A meta-analysis of 25 articles with 2,670 participants evaluated the efficacy of vitamin D therapy in patients with COPD. Vitamin D therapy significantly improved FEV1 (SMD: 1.21, 95% CI: 0.76-1.66, P<0.01), FEV1/FVC (SMD: 1.07, 95% CI: 0.56-1.58, P<0.01), and 6-minute walk distance (MD: 8.82, 95% CI: 1.67-15.98, P=0.02). It also significantly reduced exacerbations (SMD: 0.39, 95% CI: 0.23-0.64, P<0.01), sputum volume (SMD: -6.02, 95% CI: -8.25 to 3.79, P<0.01), and COPD assessment test score (SMD: -1.19, 95% CI: -1.74 to 0.63, P<0.01).

Study type
Meta-analysis of randomized controlled trials
Who was studied
2,670 participants with chronic obstructive pulmonary disease (COPD) across 25 articles
What was measured
FEV1, FEV1/FVC, exacerbations, sputum volume, 6-minute walk distance (6MWD), and CAT score

THE PAPER

The efficacy of vitamin D therapy for patients with COPD: a meta-analysis of randomized controlled trials.

Li X, He J, Yu M, Sun J. Ann Palliat Med, 2020.

PubMed 32156131 ↗DOI 10.21037/apm.2020.02.26 ↗

Nutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.